Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug.
about
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright FutureTargeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial ResistanceSynergy Maps: exploring compound combinations using network-based visualizationIdentification of heat shock factor binding protein in Plasmodium falciparumCharacterization of Precursor PfHsp60 in Plasmodium falciparum Cytosol during Its Asexual Development in Human ErythrocytesAdvances in Development of New Treatment for LeishmaniasisHsp90 governs dispersion and drug resistance of fungal biofilmsIn-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plantsMapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitryThe Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistanceGlobal analysis of the evolution and mechanism of echinocandin resistance in Candida glabrataA purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90)Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug designA repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodesIdentification of two novel HSP90 proteins in Babesia orientalis: molecular characterization, and computational analyses of their structure, function, antigenicity and inhibitor interaction.A review of multi-domain and flexible molecular chaperones studies by small-angle X-ray scattering.Trans-spliced heat shock protein 90 modulates encystation in Giardia lambliaHsp90 inhibitors as new leads to target parasitic diarrheal diseases.Expanding the Antimalarial Drug Arsenal-Now, But How?Clinical proteomics of the neglected human malarial parasite Plasmodium vivax.Expressed sequence tag analysis of the erythrocytic stage of Plasmodium bergheiReversing the resistance phenotype of the Biomphalaria glabrata snail host Schistosoma mansoni infection by temperature modulation.A small heat shock protein is essential for thermotolerance and intracellular survival of Leishmania donovani.17-AAG kills intracellular Leishmania amazonensis while reducing inflammatory responses in infected macrophages.Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic designPost-transcriptional repair of a split heat shock protein 90 gene by mRNA trans-splicing.Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.Functional characterization of heat-shock protein 90 from Oryza sativa and crystal structure of its N-terminal domainMolecular Chaperones of Leishmania: Central Players in Many Stress-Related and -Unrelated Physiological Processes.Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasitesAntimalarial activity of the anticancer histone deacetylase inhibitor SB939.Characterization of HSP90 isoforms in transformed bovine leukocytes infected with Theileria annulataFirst Structural View of a Peptide Interacting with the Nucleotide Binding Domain of Heat Shock Protein 90Human, vector and parasite Hsp90 proteins: A comparative bioinformatics analysis.Potential Interaction of Plasmodium falciparum Hsp60 and CalpainImidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development.Potent antitrypanosomal activities of heat shock protein 90 inhibitors in vitro and in vivo.A review of recent patents on the protozoan parasite HSP90 as a drug targetIn vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.HDAC inhibitors in parasitic diseases.
P2860
Q26748800-52375BC0-56A2-44A0-8F9B-A343EEA38E8EQ26864290-ACE6B200-8D8F-4F71-ACBA-44C4B89AEDD2Q27902355-822EE400-68B1-4FD2-8891-1C8A40082677Q27972683-3E9B3371-2124-414A-A4B4-4ADF36A994C2Q27973658-5D75CFB9-BBB3-4754-BCE2-CE21ACA64267Q28082097-FD355E49-E502-4EE3-BEC4-D5868A83D927Q28476836-1BCE4C2A-11B4-4E4B-977B-1365C0601CBDQ28481512-027FD218-78E9-4171-B8FC-18FBF74E6DA3Q28481516-86728BF0-6E2E-45D1-95A5-C522FB65187DQ28483590-05AEE375-237E-4D79-B78A-A38A92638281Q28483785-522E1A5B-927B-469D-A676-391EDD66EC79Q28533944-586D1FC5-FA62-474A-A671-A2AE28890F45Q28534499-CAC0E443-6EFE-46BC-A7F3-DD40DE12FE6FQ28539772-9613A441-E260-4D1E-89B4-FA514CFAB250Q30364037-6372CF85-5E71-475A-98EC-00919CEDDE41Q30402024-C5E80F76-8AD6-48E2-A941-5C86890095F1Q33553049-7BDAB1E2-BBA5-4FA3-80D1-DA5955F9A177Q33798454-8C4EA909-0C00-4974-9AA6-CC5C91292B21Q33916111-B785D1A7-C38D-4677-8DD5-90E5952F0CD5Q34058745-C86E1F2A-93B2-4928-9165-03D654CCE9D9Q34071314-A8CE3738-5EB6-4F3B-841A-EC7A9549946DQ34266050-774BC36C-581A-4E16-8635-1871EB51625FQ34433468-FFD1D144-6E02-488A-8D3D-6943421B93C2Q34478035-909B1570-B455-4AFD-AD55-96CF895C5789Q34510075-736BA51E-EDAC-4346-8947-7E59F9DBBF87Q34606166-56912DE7-5851-4B49-A3AD-5C0802F6CD59Q34915636-DE6D500F-A513-421E-A56F-70584FAC7ED7Q35705055-08A635FF-960A-4EB2-BF1C-8E774904D5D9Q35808069-BD54E282-958C-46A8-B867-165FDBB1B27FQ35864886-6625DBEA-8C63-44D5-87DA-87469F04F486Q36086326-BB420061-E861-423B-9E6B-79B53D8BA922Q36138241-1AF785C3-5352-4DFB-ABDC-6F874D1E59D8Q36310262-BC968931-A641-45B6-AE46-B9D719DF654EQ36396658-5AEEE7A7-5DFE-4B0E-9E1E-4D881DD1B3EFQ36497356-99F61186-C868-44EC-A934-04F0927C08FFQ36644848-A9EAEA5D-6729-4F8A-95CA-AB8498A62A16Q36974927-945D04BE-98CD-4B44-B88A-FAB560BC85E2Q36998394-0391888B-2F73-4B00-8AFE-09BE424B0375Q37460707-5172765C-335D-49EA-9620-B31267A5013AQ37962336-770CDFF4-E295-4855-967D-27869D32D58B
P2860
Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@ast
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@en
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@nl
type
label
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@ast
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@en
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@nl
prefLabel
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@ast
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@en
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@nl
P2093
P2860
P356
P1476
Heat shock protein 90 as a dru ...... inhibitor as a candidate drug.
@en
P2093
Ashok Kumar Gupta
Nainita Roy
Raghunath Reddy
Raj Kumar Singh
Rajender Kumar
Rani Pallavi
Rishi Kumar Nageshan
S Venketesh
Soundara Raghavan Pavithra
Suresh Chandra Yadav
P2860
P304
37964-37975
P356
10.1074/JBC.M110.155317
P407
P577
2010-09-13T00:00:00Z